Your browser doesn't support javascript.
loading
Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
Day, Emma; Hellard, Margaret; Treloar, Carla; Bruneau, Julie; Martin, Natasha K; Øvrehus, Anne; Dalgard, Olav; Lloyd, Andrew; Dillon, John; Hickman, Matt; Byrne, Jude; Litwin, Alain; Maticic, Mojca; Bruggmann, Philip; Midgard, Havard; Norton, Brianna; Trooskin, Stacey; Lazarus, Jeffrey V; Grebely, Jason.
Afiliação
  • Day E; Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine, Sydney, New South Wales, Australia.
  • Hellard M; Disease Elimination Program, Burnet Institute, Melbourne, Victoria, Australia.
  • Treloar C; Centre for Social Research in Health, UNSW Sydney, Sydney, New South Wales, Australia.
  • Bruneau J; CHUM Research Centre (CRCHUM), Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
  • Martin NK; Division of Global Public Health, University of California, San Diego, California.
  • Øvrehus A; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.
  • Dalgard O; Department of Infectious Diseases, Institute of Clinical Medicine, Akershus University Hospital, University of Oslo, Oslo, Norway.
  • Lloyd A; The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.
  • Dillon J; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, UK.
  • Hickman M; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Byrne J; Australian Injecting & Illicit Drug Users League, Canberra, Australian Capital Territory, Australia.
  • Litwin A; University of South Carolina School of Medicine Greenville, Greenville, South Carolina.
  • Maticic M; Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Bruggmann P; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Midgard H; Arud Centres for Addiction Medicine, Zürich, Switzerland.
  • Norton B; Department of Gastroenterology, Institute of Clinical Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Trooskin S; University of South Carolina School of Medicine Greenville, Greenville, South Carolina.
  • Lazarus JV; Philadelphia FIGHT, Philadelphia, Pennsylvania.
  • Grebely J; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Liver Int ; 39(1): 20-30, 2019 01.
Article em En | MEDLINE | ID: mdl-30157316
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C / Erradicação de Doenças / Programas Governamentais Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abuso de Substâncias por Via Intravenosa / Hepatite C / Erradicação de Doenças / Programas Governamentais Tipo de estudo: Etiology_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Liver Int Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália